Financials in USD. Standardized financial statements.
A compact view of how Park Ha Biological Technology Co., Ltd. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.38M | $2.46M | $1.92M | $931,036 | $456.00M | $622.00M | $790.00M | $639.00M | $2.84B | $2.74B |
| Revenue Growth? | -3.1% | +28.1% | +106.2% | -99.8% | -26.7% | -21.3% | +23.6% | -77.5% | +3.6% | 0.0% |
| Cost of Revenue? | $195,336 | $310,989 | $509,162 | $311,162 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $2.19M | $2.15M | $1.41M | $619,874 | $456.00M | $622.00M | $790.00M | $639.00M | $2.84B | $2.74B |
| Gross Margin? | +91.8% | +87.4% | +73.5% | +66.6% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | $1.39M | $967,559 | $1.21M | $1.12M | -$752.00M | -$935.00M | -$1.02B | -$657.00M | -$2.63B | -$2.71B |
| Operating Income? | $793,714 | $1.18M | $197,024 | -$501,000 | -$296.00M | -$313.00M | -$227.00M | -$18.00M | $212.00M | $28.00M |
| EBITDA? | $816,400 | $1.20M | $220,695 | -$445,000 | -$282.00M | -$297.00M | -$209.00M | $5.00M | $1.46B | $1.26B |
| Income Before Tax | $793,421 | $1.18M | $190,010 | -$485,000 | -$273.00M | -$304.00M | -$213.00M | -$284.00M | $241.00M | $87.00M |
| Income Tax Expense | $314,860 | $329,527 | -$1,288 | $0 | -$79.00M | -$111.00M | -$82.00M | -$99.00M | $77.00M | -$6.00M |
| Net Income? | $478,561 | $852,042 | $191,298 | -$485,000 | -$194.00M | -$193.00M | -$131.00M | -$185.00M | $135.00M | $34.00M |
| EPS? | $0.02 | $0.03 | $0.01 | $-0.02 | $-4.14 | $-3.60 | $-2.37 | $-3.36 | $2.36 | $0.60 |
| Diluted EPS? | $0.02 | $0.03 | $0.01 | $-0.02 | $-4.14 | $-3.60 | $-2.37 | $-3.36 | $2.06 | $0.56 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality